Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genetic Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05675813
What this trial is testing

Genotype-guided Treatment in Newly Diagnosed PTCL

Who this might be right for
Peripheral T Cell Lymphoma
Ruijin Hospital 264
Testing effectiveness (Phase 2)Study completedNCT01303380
What this trial is testing

Canakinumab in Patients With Active Hyper-IgD Syndrome

Who this might be right for
Mevalonate Kinase Deficiency
Novartis Pharmaceuticals 9
Post-approval studies (Phase 4)Study completedNCT00028262
What this trial is testing

Cystagon to Treat Infantile Neuronal Ceroid Lipofuscinosis

Who this might be right for
Infantile Neronal Ceroid Lipofuscinosis
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 10
Testing effectiveness (Phase 2)WithdrawnNCT04325802
What this trial is testing

Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone

Who this might be right for
Atopic DermatitisPruritusPruritus Chronic+1 more
University of Minnesota
Large-scale testing (Phase 3)Study completedNCT04058353
What this trial is testing

VX-445 Combination Therapy in Cystic Fibrosis (CF) Subjects Heterozygous for F508del and a Gating or Residual Function Mutation (F/G and F/RF Genotypes)

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 271
Testing effectiveness (Phase 2)UnknownNCT01883219
What this trial is testing

TKI Therapy Based on Molecular Monitoring in Allogeneic-HSCT Recipients With Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia

Who this might be right for
Philadelphia Chromosome Positive Acute Lymphocytic LeukemiaStem Cell TransplantationMinimal Residual Disease
Nanfang Hospital, Southern Medical University 80
Not applicableStudy completedNCT02825667
What this trial is testing

Effectiveness of the Myofascial Therapy in the Hemophilic Arthropathy of Ankle

Who this might be right for
Haemophilia
Real Fundación Victoria Eugenia 65
Testing effectiveness (Phase 2)Ended earlyNCT01349192
What this trial is testing

Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF)

Who this might be right for
Cystic FibrosisMethicillin-resistant Staphylococcus Aureus
University of North Carolina, Chapel Hill 47
Not applicableUnknownNCT03859531
What this trial is testing

Gastrointestinal Study at Orkambi Therapy in CF Patients

Who this might be right for
Cystic Fibrosis
Karolinska University Hospital 20
Not applicableLooking for participantsNCT07229430
What this trial is testing

Safety and Effectiveness Evaluation of the High-intensity Focused Ultrasound Device for Lifting Lax Submental and Neck Tissue

Who this might be right for
Skin Laxity (Submental and Neck)Facial Skin LaxitySubmental Tissue Laxity
CLASSYS Inc. 273
Large-scale testing (Phase 3)Active Not RecruitingNCT06224907
What this trial is testing

Phase 3 Study for Efficacy and Safety Outcomes Data in Japanese Patients With Severe Hemophilia A

Who this might be right for
Hemophilia A
BioMarin Pharmaceutical 6
Not applicableStudy completedNCT03317171
What this trial is testing

Safety and Efficacy of a Flavonoids- and omega3s-based Compound for the Treatment of Muscular Dystrophies

Who this might be right for
Muscular DystrophiesMuscle Inflammation
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico 29
Large-scale testing (Phase 3)Study completedNCT00662675
What this trial is testing

The Efficacy and Tolerability of Pancrelipase Microtablet (MT) Capsules for the Treatment of Cystic Fibrosis-dependent Exocrine Pancreatic Insufficiency

Who this might be right for
Exocrine Pancreatic InsufficiencySteatorrheaMalabsorption Syndromes+1 more
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 40
Very early researchEnded earlyNCT01694381
What this trial is testing

Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor

Who this might be right for
Acute Ischemic Stroke
TSI, LLC 8
Large-scale testing (Phase 3)Study completedNCT00790400
What this trial is testing

Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM)

Who this might be right for
Tuberous Sclerosis Complex (TSC)Lymphangioleiomyomatosis (LAM)
Novartis Pharmaceuticals 118
Testing effectiveness (Phase 2)Study completedNCT04201834
What this trial is testing

Risperidone for the Treatment of Huntington's Disease Involuntary Movements

Who this might be right for
Huntington DiseaseChorea
University of Rochester 6
Not applicableStudy completedNCT02976753
What this trial is testing

Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products

Who this might be right for
Hemophilia A
Swedish Orphan Biovitrum 361
Testing effectiveness (Phase 2)Study completedNCT01619657
What this trial is testing

Preventive Inhalation of Hypertonic Saline in Infants With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis Lung Disease
Heidelberg University 42
Not applicableStudy completedNCT02022891
What this trial is testing

Systematic Psychological and Medical Care for Children With SCD

Who this might be right for
Anemia, Sickle Cell
Fondation Ophtalmologique Adolphe de Rothschild 160
Large-scale testing (Phase 3)Looking for participantsNCT05577988
What this trial is testing

Assessment of an Early De-Escalation to a Low-potency Single Antiplatelet Therapy Guided by Genetics Versus a Systematic High-Potency Single Antiplatelet Therapy to Neutralize Bleeding Complications in Patients With High Bleeding Risk Beyond One Month After an Acute Coronary Syndrome

Who this might be right for
MYOCARDIAL INFARCTION
Assistance Publique - Hôpitaux de Paris 2,468
Next Page